IBDEI0CY ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6167,1,5,0)
 ;;=5^Elevated BP w/o HTN
 ;;^UTILITY(U,$J,358.3,6167,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,6168,0)
 ;;=607.84^^41^497^35
 ;;^UTILITY(U,$J,358.3,6168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6168,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,6168,1,5,0)
 ;;=5^Erectile Dysfunction
 ;;^UTILITY(U,$J,358.3,6168,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,6169,0)
 ;;=530.81^^41^497^36
 ;;^UTILITY(U,$J,358.3,6169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6169,1,4,0)
 ;;=4^530.81
 ;;^UTILITY(U,$J,358.3,6169,1,5,0)
 ;;=5^GERD
 ;;^UTILITY(U,$J,358.3,6169,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,6170,0)
 ;;=389.9^^41^497^39
 ;;^UTILITY(U,$J,358.3,6170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6170,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,6170,1,5,0)
 ;;=5^Hearing Loss NOS
 ;;^UTILITY(U,$J,358.3,6170,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,6171,0)
 ;;=784.0^^41^497^38
 ;;^UTILITY(U,$J,358.3,6171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6171,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,6171,1,5,0)
 ;;=5^Headaches
 ;;^UTILITY(U,$J,358.3,6171,2)
 ;;=^54133
 ;;^UTILITY(U,$J,358.3,6172,0)
 ;;=070.54^^41^497^40
 ;;^UTILITY(U,$J,358.3,6172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6172,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,6172,1,5,0)
 ;;=5^Hepatitis C
 ;;^UTILITY(U,$J,358.3,6172,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,6173,0)
 ;;=272.4^^41^497^41
 ;;^UTILITY(U,$J,358.3,6173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6173,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,6173,1,5,0)
 ;;=5^Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,6173,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,6174,0)
 ;;=272.2^^41^497^42
 ;;^UTILITY(U,$J,358.3,6174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6174,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,6174,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,6174,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,6175,0)
 ;;=401.9^^41^497^43
 ;;^UTILITY(U,$J,358.3,6175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6175,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,6175,1,5,0)
 ;;=5^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,6175,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,6176,0)
 ;;=244.9^^41^497^44
 ;;^UTILITY(U,$J,358.3,6176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6176,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,6176,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,6176,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,6177,0)
 ;;=790.21^^41^497^45
 ;;^UTILITY(U,$J,358.3,6177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6177,1,4,0)
 ;;=4^790.21
 ;;^UTILITY(U,$J,358.3,6177,1,5,0)
 ;;=5^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,6177,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,6178,0)
 ;;=790.5^^41^497^51
 ;;^UTILITY(U,$J,358.3,6178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6178,1,4,0)
 ;;=4^790.5
 ;;^UTILITY(U,$J,358.3,6178,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,6178,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,6179,0)
 ;;=724.2^^41^497^52
 ;;^UTILITY(U,$J,358.3,6179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6179,1,4,0)
 ;;=4^724.2
 ;;^UTILITY(U,$J,358.3,6179,1,5,0)
 ;;=5^Low Back Pain,Chronic
 ;;^UTILITY(U,$J,358.3,6179,2)
 ;;=^71885
 ;;^UTILITY(U,$J,358.3,6180,0)
 ;;=412.^^41^497^56
 ;;^UTILITY(U,$J,358.3,6180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6180,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,6180,1,5,0)
 ;;=5^Myocardial Infarction-Old
 ;;^UTILITY(U,$J,358.3,6180,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,6181,0)
 ;;=250.60^^41^497^58
 ;;^UTILITY(U,$J,358.3,6181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6181,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,6181,1,5,0)
 ;;=5^Neuropathy,Diabetic
